PHARMEDAILY

Trump Signs Executive Order to Cut Drug Prices…Benefits for Korean biosimilars?

• 김새미
• 2025.04.17
• 오전 09:11

K-Bio Stocks Fall as Tariff Concerns Offset Political Clarity[K-Bio Pulse]

• 나은경
• 2025.04.07
• 오전 07:49

Celltrion, Track to Achieve 5 Trillion won in Annual Revenue This Year with Successful U.S. Expan...

• 신민준
• 2025.03.06
• 오전 10:10